(Q47822658)

5 February 2018

title

Inhibitory effect of somatostatin on human T lymphocytes proliferation. (English)

1 reference

5 February 2018

author name string

Casnici C

1

1 reference

5 February 2018

Lattuada D

2

1 reference

5 February 2018

Perego C

3

1 reference

5 February 2018

Franco P

4

1 reference

5 February 2018

Marelli O

5

1 reference

5 February 2018

publication date

1 November 1997

1 reference

5 February 2018

International Journal of Immunopharmacology

published in

1 reference

5 February 2018

volume

19

1 reference

5 February 2018

issue

11-12

1 reference

5 February 2018

page(s)

721-727

1 reference

5 February 2018

Effects of somatostatin on human intestinal lamina propria lymphocytes. Modulation of lymphocyte activation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

The B7 and CD28 receptor families

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

The role of the CD28 receptor during T cell responses to antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

Anti-CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation. I. Pairs of anti-T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12-O-tetradecanoylphorbol 13-acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

G protein activation of a hormone-stimulated phosphatase in human tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

CD3+ WT31- peripheral T lymphocytes lack T44 (CD28), a surface molecule involved in activation of T cells bearing the alpha/beta heterodimer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

Distribution of somatostatin receptors in normal and tumor tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

Somatostatin and the immune and haematopoetic system; a review

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900033-7

7 January 2021

10.1016/S0192-0561(97)00033-7

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018